Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The impact of lipoperoxidation monitoring in familiar hypercholesterolaemia treated by extracorporeal elimination2009 | First Faculty of Medicine
- Combined hypolipidemic treatment in patients with high cardiovascular (CV) risk2009 | First Faculty of Medicine
- Extracorporeal LDL-cholesterol elimination (25 years of experience in CZ)2009 | First Faculty of Medicine
- Therapeutic plasmapheresis and more specific methods of extracorporeal LDL-cholesterol elimination2009 | First Faculty of Medicine
- Hypolipidemic drugs and diabetes mellitus2009 | First Faculty of Medicine
- Cholesterol metabolism in active Crohn's disease2009 | First Faculty of Medicine
- Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia2008 | First Faculty of Medicine
- Reological efect of extracorporeal elimination of LDL cholesterol in patient with peripheral arterial occlusive disease (PAOD) and diabetes mellitus (DM)2008 | First Faculty of Medicine
- Changes of metabolism and hemostasis in familial hypercholetsrolemia treated with LDL-apheresis2007 | First Faculty of Medicine
Loading network view...